ArticleBiomedicines2026

Three-Month Treatment with Monoclonal Antibodies Targeting the CGRP Pathway Is Associated with Multi-Domain Changes in Sensory Processing and Cortical Network Efficiency in Migraine: Results from a Prospective Case-Control Study.

Lara Klehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.